Preclinical development of a B7-H3-targeting ADC with a novel DNA topoisomerase I inhibitor for solid tumors

被引：0
|
作者：
Li, Chenggang
Yao, Jun
Qu, Chen
Li, Bing
Zhang, Yu
Shi, Rong
Qiu, Yang
Hua, Haiqing
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2967
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2967
引用
收藏
页数：2
相关论文
共 50 条
  • [31] CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
    Majzner, Robbie G.
    Theruvath, Johanna L.
    Nellan, Anandani
    Heitzeneder, Sabine
    Cui, Yongzhi
    Mount, Christopher W.
    Rietberg, Skyler P.
    Linde, Miles H.
    Xu, Peng
    Rota, Christopher
    Sotillo, Elena
    Labanieh, Louai
    Lee, Daniel W.
    Orentas, Rimas J.
    Dimitrov, Dimiter S.
    Zhu, Zhongyu
    St Croix, Brad
    Delaidelli, Alberto
    Sekunova, Alla
    Bonvini, Ezio
    Mitra, Siddhartha S.
    Quezado, Martha M.
    Majeti, Ravindra
    Monje, Michelle
    Sorensen, Poul H. B.
    Maris, John M.
    Mackall, Crystal L.
    CLINICAL CANCER RESEARCH, 2019, 25 (08) : 2560 - 2574
  • [32] CAR T CELLS TARGETING B7-H3, A PAN-CANCER ANTIGEN, DEMONSTRATE POTENT PRECLINICAL ACTIVITY AGAINST PEDIATRIC SOLID TUMORS AND BRAIN TUMORS
    Majzner, Robbie
    Nellan, Anandani
    Heitzeneder, Sabine
    Theruvath, Johanna
    Mackall, Crystal
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [33] 212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models
    Kasten, Benjamin B.
    Gangrade, Abhishek
    Kim, Harrison
    Fan, Jinda
    Ferrone, Soldano
    Ferrone, Cristina R.
    Zinn, Kurt R.
    Buchsbaum, Donald J.
    NUCLEAR MEDICINE AND BIOLOGY, 2018, 58 : 67 - 73
  • [34] Incorporating Radioimmunotherapy Targeting B7H3 in Pediatric Tumors
    Kramer, Kim
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [35] A phase I study of the novel DNA topoisomerase-1 inhibitor, TLC388, administered intravenously to patients with advanced solid tumors.
    Ghamande, S. A.
    Lin, C.
    Cho, D. C.
    Coleman, T. A.
    Chaudhary, I.
    Cleary, J. M.
    Silverman, M. H.
    Kuo, M.
    Mach, W.
    Tseng, Y.
    Hsu, S. C.
    Goel, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [36] Novel conditionally active tetravalent B7-H3 x CD3 T-cell engagers targeting solid tumors
    Cugnetti, Ana Paula
    Liu, Haizhen
    McNeeley, Patricia
    Woodard, Kathryn
    Chang, Cathy
    Frey, Gerhard
    Boyle, William J.
    Short, Jay M.
    CANCER RESEARCH, 2024, 84 (06)
  • [37] DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1
    Ogitani, Yusuke
    Aida, Tetsuo
    Hagihara, Katsunobu
    Yamaguchi, Junko
    Ishii, Chiaki
    Harada, Naoya
    Soma, Masako
    Okamoto, Hiromi
    Oitate, Masataka
    Arakawa, Shingo
    Hirai, Takehiro
    Atsumi, Ryo
    Nakada, Takashi
    Hayakawa, Ichiro
    Abe, Yuki
    Agatsuma, Toshinori
    CLINICAL CANCER RESEARCH, 2016, 22 (20) : 5097 - 5108
  • [38] Preclinical development of MGC018, a duocarmycin-based antibody-drug conjugate targeting B7-H3 for solid cancer
    Scribner, Juniper A.
    Brown, Jennifer G.
    Sharma, Sharad
    Li, Hua
    Chiechi, Michael
    Li, Pam
    Son, Thomas
    De Costa, Anushka
    Chen, Yan
    Chen, Francine
    Barat, Bhaswati
    Huang, Ling
    Wolff, Christina
    Hooley, Jeff
    Hotaling, Tim E.
    Gaynutdinov, Timur
    Ciccarone, Valentina
    Tamura, James
    Koenig, Scott
    Johnson, Syd
    Moore, Paul A.
    Bonvini, Ezio
    Loo, Deryk
    CANCER RESEARCH, 2018, 78 (13)
  • [39] Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid Cancer
    Scribner, Juniper A.
    Brown, Jennifer G.
    Son, Thomas
    Chiechi, Michael
    Li, Pam
    Sharma, Sharad
    Li, Hua
    De Costa, Anushka
    Li, Ying
    Chen, Yan
    Easton, Ann
    Yee-Toy, Nicholas C.
    Chen, Francine Z.
    Gorlatov, Sergey
    Barat, Bhaswati
    Huang, Ling
    Wolff, Christina R.
    Hooley, Jeff
    Hotaling, Tim E.
    Gaynutdinov, Timur
    Ciccarone, Valentina
    Tamura, James
    Koenig, Scott
    Moore, Paul A.
    Bonvini, Ezio
    Loo, Deryk
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (11) : 2235 - 2244
  • [40] A phase 1/2a, multicenter, open-label, first-in-human study to assess the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of DB-1311 (a B7-H3-targeting ADC) in patients with advanced/metastatic solid tumors
    Cheng, Ying
    Lisberg, Aaron
    Lemech, Charlotte
    Abed, Afaf
    Chaudhry, Arvind
    Schmidt, Andrew
    Lu, Xin
    Zhu, Zhongyuan
    Gu, Wei
    Qiu, Yang
    Shi, Rong
    Zhang, Bin
    CANCER RESEARCH, 2024, 84 (07)
12345